Ethnopharmacology Study and Therapeutic Potential of Cassia alata for Skin Diseases

  • Vongphachanh Khampheng
  • Nanludet Phoummixay
  • Onmavong Sythanonxay
Keywords: Antimicrobial, Anti-Inflammatory, Cassia alata, Fungal Infection, Skin Disease

Abstract

This study explores the ethnopharmacological knowledge of Cassia alata in the treatment of skin diseases in rural Laotian communities. Traditional practices highlight the use of the plant to treat fungal infections, eczema, and other skin conditions, driven by its antimicrobial and anti-inflammatory properties. This study aimed to document and scientifically validate the therapeutic applications of Cassia alata, with a focus on its safety, efficacy, and potential for dermatological product development. A mixed methods approach was used, involving ethnographic interviews with members of a rural Laotian community, laboratory tests to assess antimicrobial activity, and dermatological safety testing. The findings revealed that Cassia alata is widely used in rural areas, with a high degree of confidence in its ability to treat a variety of skin conditions. Microbiological tests confirmed its effectiveness against common pathogens such as Trichophyton and Candida, while dermatological tests demonstrated its safety with minimal side effects. The potential of the plant for dermatological product development is significant, with potential for commercialization and economic benefits to the local community. However, further research is needed to identify active compounds, assess long-term use, and optimize product formulations. This study provides a basis for future research on the global application of Cassia alata as a natural dermatological treatment.

Downloads

Download data is not yet available.

Author Biographies

Vongphachanh Khampheng

Department of Traditional Medicine and Pharmacology, Savannakhet University. Savannakhet, Laos.

Nanludet Phoummixay

Department of Traditional Medicine and Pharmacology, Savannakhet University. Savannakhet, Laos.

Onmavong Sythanonxay

School of Pharmaceutical Sciences, Champasack University. Pakse, Laos.

This is an open access article, licensed under CC-BY-SA

Creative Commons License
Published
        Views : 765
2024-11-27
    Downloads : 259
How to Cite
Khampheng, V., Phoummixay, N., & Sythanonxay, O. (2024). Ethnopharmacology Study and Therapeutic Potential of Cassia alata for Skin Diseases. Journal of Advances in Medicine and Pharmaceutical Sciences, 3(2), 71-78. https://doi.org/10.36079/lamintang.jamaps-0302.775
Section
Articles

References

S. C. Toh, S. Lihan, S. R. Bunya, and S. S. Leong, “In vitro antimicrobial efficacy of Cassia alata (Linn.) leaves, stem, and root extracts against cellulitis causative agent Staphylococcus aureus,” BMC Complementary Medicine and Therapies, vol. 23, no. 1, 2023.

J. A. L. Yon, S. K. Lee, J. W. Keng et al., “Cassia alata (Linnaeus) Roxburgh for skin: Natural remedies for atopic dermatitis in Asia and their pharmacological activities,” Cosmetics, vol. 10, no. 1, 2023.

V. A. Agampodi and T. Collet, “Anti-inflammatory effects and keratinocyte regenerative potential of Cassia alata (Linn) leaf extracts and their implications for wound healing,” Journal of Applied Biological Sciences, vol. 16, no. 3, pp. 503–526, 2022.

B. C. Sikora, M. Wortzman, D. B. Nelson, and J. S. Dover, “A pilot study evaluating the efficacy and tolerability of a comprehensive, hydrating topical antioxidant developed specifically for men,” Journal of Cosmetic Dermatology, vol. 20, no. 9, pp. 2816–2823, 2021.

E. Emmanuel, O. O. Martin-Luther, S. A. Adetunji et al., “Phytochemical screening and antifungal activity of Cassia alata (Linn.) crude leaf extracts,” African Journal of Microbiology Research, vol. 17, no. 8, pp. 176–183, 2023.

Y.-L. Chew et al., “Cassia alata, Coriandrum sativum, Curcuma longa, and Azadirachta indica: Food ingredients as complementary and alternative therapies for atopic dermatitis-A comprehensive review,” Molecules, vol. 27, no. 17, 2022.

S.-G. Kim, J. G. Choi, and Y.-A. Jang, “Emodin studies on anti-inflammatory and skin barrier improvement activities,” Journal of Korean Applied Science and Technology, vol. 38, pp. 1383–1392, 2021.

C.-x. Liu, “Overview on development of ASEAN traditional and herbal medicines,” Chinese Herbal Medicines, vol. 13, no. 4, pp. 441–450, 2021.

M. Bounlu et al., “Management of epilepsy in Laos: Perceptions of healthcare professionals from Vientiane Capital province and traditional healers in Southern Laos,” Journal of Traditional and Complementary Medicine, vol. 11, no. 1, pp. 46–52, 2021.

X. J. Gu, X. L. Zhou, L. Y. Yu, X. Lin, J. H. Miao, and L. Q. Huang, “Compilation and research summary of herbal pharmacopoeia of Lao People's Democratic Republic,” Chinese Journal of Experimental Traditional Medical Formulae, vol. 27, no. 10, pp. 169–175, 2021.

K. S. Lee, Y. Walid, Y. W. Kassa, N. A. Taha, and Z. A. Zainal, “Factors impacting pharmaceutical prices and affordability: Narrative review,” Pharmacy (Basel), vol. 9, no. 1, 2021.

S. L. Muhammad et al., “Bioassay-guided identification of bioactive compounds from Senna alata L. against methicillin-resistant Staphylococcus aureus,” Applied Microbiology, vol. 1, pp. 520–536, 2021.

P. Ogonowska, Y. Gilaberte, W. Barańska-Rybak, and J. Nakonieczna, “Colonization with Staphylococcus aureus in atopic dermatitis patients: Attempts to reveal the unknown,” Frontiers in Microbiology, vol. 11, 2021.

Y.-G. Shi et al., “On the mechanism behind enhanced antibacterial activity of alkyl gallate esters against foodborne pathogens and its application in Chinese icefish preservation,” Food Microbiology, vol. 99, 2021.

S. L. Muhammad et al., “Bioassay-guided identification of bioactive compounds from Senna alata L. against methicillin-resistant Staphylococcus aureus,” Applied Microbiology, vol. 1, pp. 520–536, 2021.

A. Gunaydin-Akyildiz et al., “Emodin and aloe-emodin, two potential molecules in regulating cell migration of skin cells through the MAP kinase pathway and affecting Caenorhabditis elegans thermotolerance,” BMC Molecular and Cell Biology, vol. 24, 2023.

S N. Chaachouay and L. Zidane, “Plant-Derived Natural Products: A Source for Drug Discovery and Development,” Drugs Drug Candidates, vol. 3, no. 1, pp. 184-207, 2024.

C. Proença, D. Ribeiro, M. Freitas, F. Carvalho, and E. Fernandes, “A comprehensive review on the antidiabetic activity of flavonoids targeting PTP1B and DPP-4: A structure-activity relationship analysis,” Crit. Rev. Food Sci. Nutr., vol. 62, pp. 4095–4151, 2022.

E. U. Alum, “The role of indigenous knowledge in advancing the therapeutic use of medicinal plants: challenges and opportunities,” Plant Signaling & Behavior, vol. 19, no. 1, 2024.

D. Domingo-Fernández, Y. Gadiya, S. Mubeen, T. J. Bollerman, M. D. Healy, S. Chanana, R. Gura Sadovsky, D. Healey, and V. Colluru, “Modern drug discovery using ethnobotany: A large-scale cross-cultural analysis of traditional medicine reveals common therapeutic uses,” iScience, vol. 26, no. 9, 2023.

C. P. Austin, “Opportunities and challenges in translational science,” Clin. Transl. Sci., vol. 14, no. 5, pp. 1629–1647, 2021.

V. Subbiah, “The next generation of evidence-based medicine,” Nat. Med., vol. 29, pp. 49–58, 2023.

R. Gang, D. Okello, and Y. Kang, “Medicinal plants used for cutaneous wound healing in Uganda; ethnomedicinal reports and pharmacological evidences,” Heliyon, vol. 10, no. 9, 2024.

F. O. Atanu, D. Rotimi, and P. A. Idakwoji, “Hydroethanolic Extracts of Senna alata Leaves Possess Antimalarial Effects and Reverses Haematological and Biochemical Perturbation in Plasmodium berghei-infected Mice,” J. Evid. - Based Integr. Med., vol. 18, no. 3, 2022.